A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics... - PubMed - NCBI
Pharmacogenomics. 2017 Feb;18(3):215-225. doi: 10.2217/pgs-2016-0138. Epub 2017 Jan 23.
A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations.
Abstract
AIM:
To benchmark Dutch pharmacists knowledge, experience and attitudes toward pharmacogenetics (PGx) with a specific focus on the effects of awareness of the Dutch Pharmacogenetics Working Group guidelines. METHODS:
A web-based survey containing 41 questions was sent to all certified Dutch pharmacists. RESULTS:
A total of 667 pharmacists completed the survey (18.8%). Virtually all responders believed in the concept of PGx (99.7%). However, only 14.7% recently ordered a PGx test (≤6 months), 14.1% felt adequately informed and 88.8% would like to receive additional training on PGx. Being aware of the Dutch Pharmacogenetics Working Group guidelines did not have any significant effect on knowledge or adoption of PGx. CONCLUSION:
Dutch pharmacists are very positive toward PGx. However, test adoption is low and additional training is warranted. KEYWORDS:
clinical practice; pharmacists; pharmacogenetics
No hay comentarios:
Publicar un comentario